144 related articles for article (PubMed ID: 32446996)
21. Spectrum of cytomorphological features of extranodal NK/T-cell lymphoma, nasal type.
Kaur K; Kakkar A; Bhardwaj N; Sakthivel P; Singh CA; Jain D; Mathur SR; Iyer VK; Sood R
Cytopathology; 2019 Jul; 30(4):393-401. PubMed ID: 30980430
[TBL] [Abstract][Full Text] [Related]
22. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.
Tian S; Li R; Wang T; Wang S; Tao R; Hu X; Ding H
Cancer Med; 2019 Jul; 8(7):3349-3358. PubMed ID: 31050212
[TBL] [Abstract][Full Text] [Related]
24. Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.
Mori H; Ebisawa K; Nishimura M; Kanazawa K
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455176
[TBL] [Abstract][Full Text] [Related]
25. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
[TBL] [Abstract][Full Text] [Related]
26. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
[TBL] [Abstract][Full Text] [Related]
27. [Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].
Sasaki Y; Yonezawa A; Kinoshita Y; Kitagawa T; Mori M; Onaka T; Imada K
Rinsho Ketsueki; 2015 Dec; 56(12):2472-6. PubMed ID: 26725358
[TBL] [Abstract][Full Text] [Related]
28. [Extranodal Natural Killer/T-Cell Lymphoma, nasal-type with primary cutaneous involvement. A case report].
Silva-Feistner M; Rojas-Lechuga MJ; Ortiz E; Molgó M
Rev Chil Pediatr; 2018 Apr; 89(2):246-250. PubMed ID: 29799894
[TBL] [Abstract][Full Text] [Related]
29. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
30. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis.
Kim JW; An JH
J Craniofac Surg; 2014 Mar; 25(2):509-11. PubMed ID: 24621697
[TBL] [Abstract][Full Text] [Related]
31. Extranodal natural killer/T-cell lymphoma, nasal-type.
Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
[TBL] [Abstract][Full Text] [Related]
32. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
33. Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula.
Wong DJY; Parry LA; Bloch AE; Agar N
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30852512
[TBL] [Abstract][Full Text] [Related]
34. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
35. Nodal presentation of nasal-type NK/T-cell lymphoma. Report of two cases with fine needle aspiration cytology findings.
Ng WK; Lee CY; Li AS; Cheung LK
Acta Cytol; 2003; 47(6):1063-8. PubMed ID: 14674081
[TBL] [Abstract][Full Text] [Related]
36. Extranodal natural killer/T-cell lymphoma nasal type.
Daines BS; Varman RM; Nguyen TQ
Proc (Bayl Univ Med Cent); 2022; 35(5):672-674. PubMed ID: 35991731
[TBL] [Abstract][Full Text] [Related]
37. Nasal-type extranodal natural killer/T-cell lymphoma presenting as a solitary non-healing lower leg ulcer.
Liaw TY; Hu SC
Australas J Dermatol; 2016 Feb; 57(1):e17-9. PubMed ID: 25496526
[TBL] [Abstract][Full Text] [Related]
38. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
39. Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as Refractory
Reategui Schwarz E; Oikonomou KG; Reynolds M; Kim J; Balmiki RL; Sterling SA
J Investig Med High Impact Case Rep; 2017; 5(3):2324709617716471. PubMed ID: 28748192
[TBL] [Abstract][Full Text] [Related]
40. [The significance of peripheral blood natural killer cell surface CD
Liu JX; Wang JW; Cui XY
Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):872-874. PubMed ID: 27801344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]